Mesoblast Participation at Piper Sandler Conference
(AUST:MSB.AX),(NASDAQ:MESO), NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its participation at the Piper Sandler 37th Annual Healthcare Conference in New York on December 2-4, 2025. Silviu Itescu, Chief Executive of Mesoblast, is scheduled for a fireside chat at 12.00 […]